Peer Reviewed News for Medical Professionals
Advertise in this space for $10 per month.
Contact us today.
Investigational drug, RI-BPI, in combination with the drug Gleevec, effective against acute lymphoblastic leukemia
Reprogramming of diseased cells back into pluripotent stem cells provides model for studying the stages of cancer development
Discovery that can lead to new drugs for Leukaemia
Screening for p53 would predict sensitivity to proteasome inhibitors
Oblimersen enhances sensitivity to chemotherapy in Chronic Lymphocytic Leukemia
African-Americans receive fewer stem cell transplants than whites
Predicting response of treatment in Multiple Myeloma patients
Lenalidomide effective in chronic lymphocytic leukemia
Medication errors affect children's leukemia treatment
JAK-STAT pathway inhibitors are likely to be effective against some leukemias
Enter your email address:
This meeting will be held May 5, 2005 at the Advisors and Consultants Staff conference room, 5630 Fishers Lane in Rockville, Md. beginning at 8:30 a.m.
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
Top of Page